Literature DB >> 14713115

Why is erythropoietin made in the kidney? The kidney functions as a 'critmeter' to regulate the hematocrit.

Sandra Donnelly1.   

Abstract

The normal hematocrit is not a random number, but one that maximizes oxygen delivery. While the feedback loop wherein tissue oxygen pressure determines the production of erythropoietin, which further drives the production of red blood cells in the bone marrow, explains how the hematocrit is generated, it does not speak to how the hematocrit is regulated. The regulation of the hematocrit requires the coordination of the plasma volume and the red cell mass. By controlling red cell mass via erythropoietin and plasma volume through excretion of salt and water, the kidney is able to generate the hematocrit. It is hypothesized that the kidney functions as a critmeter by sensing the relative volumes of each component of the blood through the common signal of tissue oxygen tension. The kidney's unique ability to sense ECF volume through tissue oxygen signal allows it to coordinate these two volumes to produce the normal hematocrit. Hence, it may be the kidneys ability to report a measure of ECF volume as a tissue oxygen signal and thus to regulate the hematocrit that establishes it as the logical site of erythropoietin production. The critmeter is proposed to be a functional unit located at the tip of the cortical labyrinth at the juxta-medullary region of the kidney where erythropoietin is made physiologically. Renal vasculature and nephron segment heterogeneity in sodium reabsorption likely provides the anatomical construct to generate the marginal tissue oxygen pressure required to trigger the production of erythropoietin. The balance of oxygen consumption for sodium reabsorption and oxygen delivery is reflected by the tissue oxygen pressure. This balance hence determines RBC mass adjusted to plasma volume. Factors that affect blood supply and sodium reabsorption in a discordant manner may modulate the critmeter, e.g. angiotensin II. The objective of this work is to describe the hypothesis of the kidney's function as a critmeter, including the anatomical and physiological components, and the role of the renin-angiotensin system in modulating erythropoietin. Clinical examples of the dysregulation of the critmeter may be found in the anemia of renal failure and in sports anemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14713115     DOI: 10.1007/978-1-4419-8997-0_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  16 in total

1.  Erythropoietin down-regulates proximal renal tubular reabsorption and causes a fall in glomerular filtration rate in humans.

Authors:  Niels Vidiendal Olsen; Niels-Jacob Aachmann-Andersen; Peter Oturai; Thor Munch-Andersen; Andreas Bornø; Carl Hulston; Niels-Henrik Holstein-Rathlou; Paul Robach; Carsten Lundby
Journal:  J Physiol       Date:  2010-08-19       Impact factor: 5.182

2.  QTL influencing baseline hematocrit in the C57BL/6J and DBA/2J lineage: age-related effects.

Authors:  Frank Johannes; David A Blizard; Arimantas Lionikas; Dena H Lang; David J Vandenbergh; Joseph T Stout; James A Strauss; Gerald E McClearn; George P Vogler
Journal:  Mamm Genome       Date:  2006-06-12       Impact factor: 2.957

3.  Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production.

Authors:  Michal Safran; William Y Kim; Fionnuala O'Connell; Lee Flippin; Volkmar Günzler; James W Horner; Ronald A Depinho; William G Kaelin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-22       Impact factor: 11.205

4.  Physiological Genomics of Adaptation to High-Altitude Hypoxia.

Authors:  Jay F Storz; Zachary A Cheviron
Journal:  Annu Rev Anim Biosci       Date:  2020-11-23       Impact factor: 8.923

5.  Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2.

Authors:  Sharon S Cooperman; Esther G Meyron-Holtz; Hayden Olivierre-Wilson; Manik C Ghosh; Joseph P McConnell; Tracey A Rouault
Journal:  Blood       Date:  2005-04-14       Impact factor: 22.113

6.  Tubulovascular cross-talk by vascular endothelial growth factor a maintains peritubular microvasculature in kidney.

Authors:  Henrik Dimke; Matthew A Sparks; Benjamin R Thomson; Sebastian Frische; Thomas M Coffman; Susan E Quaggin
Journal:  J Am Soc Nephrol       Date:  2014-11-10       Impact factor: 10.121

7.  Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD.

Authors:  Wanja M Bernhardt; Michael S Wiesener; Paul Scigalla; James Chou; Roland E Schmieder; Volkmar Günzler; Kai-Uwe Eckardt
Journal:  J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 10.121

Review 8.  Effects of recombinant human erythropoietin in normal humans.

Authors:  Carsten Lundby; Niels Vidiendal Olsen
Journal:  J Physiol       Date:  2010-08-31       Impact factor: 5.182

9.  Development of an AT2-deficient proximal tubule cell line for transport studies.

Authors:  Philip G Woost; Robert J Kolb; Chung-Ho Chang; Margaret Finesilver; Tadashi Inagami; Ulrich Hopfer
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-10-26       Impact factor: 2.416

10.  Triple-way therapeutic approach for paraganglioma-dependent erythrocytosis: drugs and surgery plus "multi-manner" apheresis.

Authors:  M Todorovic; B Balint; N Suvajdzic; M Jevtic; M Pavlovic; M Petrovic; M Krstic; V Popovic; B Ivanovic; I Elezovic; R Milenkovic; M Colovic
Journal:  Med Oncol       Date:  2007-09-25       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.